Literature DB >> 1707174

Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.

G R Foster1, A M Ackrill, R D Goldin, I M Kerr, H C Thomas, G R Stark.   

Abstract

Constructs expressing the core, surface, X, or polymerase proteins of hepatitis B virus were transfected into human cells. In transient assays, only the polymerase inhibited the responses to interferons alpha and gamma (IFN-alpha and -gamma). Stable expression of the polymerase was achieved in the cell line 2fTGH, which carries an IFN-inducible marker gene, by growth under conditions that select for inhibition of the response to IFN-alpha, but the clones grew poorly. When expressed alone, the terminal protein domain of the polymerase gene inhibited the response to IFN-alpha and the reverse transcriptase plus RNase H domains appeared to be toxic. Clones of cells expressing terminal protein alone, selected for the loss of response to IFN-alpha, grew normally and had no detectable response to IFN-alpha, IFN-gamma, or double-stranded RNA. Binding of IFN-alpha to these cells was not impaired but did not lead to activation of the E alpha subunit of the IFN-induced transcription factor E. These observations are of potential importance in relation to the pathogenesis of chronic hepatitis B virus infection and the resistance of such infection to IFN-alpha therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707174      PMCID: PMC51345          DOI: 10.1073/pnas.88.7.2888

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules.

Authors:  C V Harding; E R Unanue
Journal:  Cell Regul       Date:  1990-06

2.  Differential response of the human 6-16 and 9-27 genes to alpha and gamma interferons.

Authors:  A M Ackrill; L E Reid; C S Gilbert; D R Gewert; A C Porter; A R Lewin; G R Stark; I M Kerr
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

3.  Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells.

Authors:  T C Dale; A M Imam; I M Kerr; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Two proteins with reverse transcriptase activities associated with hepatitis B virus-like particles.

Authors:  M R Bavand; O Laub
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

5.  HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection.

Authors:  M Pignatelli; J Waters; D Brown; A Lever; S Iwarson; Z Schaff; R Gerety; H C Thomas
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

6.  Identification of a dominant immunogenic epitope of the nucleocapsid (HBc) of the hepatitis B virus.

Authors:  J A Waters; T P Jowett; H C Thomas
Journal:  J Med Virol       Date:  1986-05       Impact factor: 2.327

7.  Transcription factors induced by interferons alpha and gamma.

Authors:  A M Imam; A M Ackrill; T C Dale; I M Kerr; G R Stark
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

8.  125I-labelled human interferons alpha, beta and gamma: comparative receptor-binding data.

Authors:  G Merlin; E Falcoff; M Aguet
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

9.  Interferon response element of the human gene 6-16.

Authors:  A C Porter; Y Chernajovsky; T C Dale; C S Gilbert; G R Stark; I M Kerr
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

10.  The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription.

Authors:  R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  41 in total

Review 1.  Mechanisms of immune escape in viral hepatitis.

Authors:  W Rosenberg
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 2.  Immune escape by hepatitis B viruses.

Authors:  U Protzer; H Schaller
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

Review 3.  Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.

Authors:  Nicole E Pagliaccetti; Michael D Robek
Journal:  J Interferon Cytokine Res       Date:  2010-08       Impact factor: 2.607

4.  Modulation of MHC antigen expression by viruses and oncogenes.

Authors:  D J Maudsley; J D Pound
Journal:  Immunol Today       Date:  1991-12

5.  Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene.

Authors:  A M Ackrill; G R Foster; C D Laxton; D M Flavell; G R Stark; I M Kerr
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

Review 6.  Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.

Authors:  Jieliang Chen; Zhenghong Yuan
Journal:  Virol Sin       Date:  2014-01-20       Impact factor: 4.327

Review 7.  Tumor-suppressor genes: news about the interferon connection.

Authors:  P Lengyel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways.

Authors:  L G Guidotti; S Guilhot; F V Chisari
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.

Authors:  L G Guidotti; P Borrow; M V Hobbs; B Matzke; I Gresser; M B Oldstone; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

10.  Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.

Authors:  J Y Lau; G L Bird; N V Naoumov; R Williams
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.